EMA — authorised 26 April 2019
- Marketing authorisation holder: AbbVie Deutschland GmbH & Co KG
- Status: approved
🇪🇺 Skyrizi in European Union
EMA authorised Skyrizi on 26 April 2019
Marketing authorisation
Skyrizi in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in European Union
Frequently asked questions
Is Skyrizi approved in European Union?
Yes. EMA authorised it on 26 April 2019.
Who is the marketing authorisation holder for Skyrizi in European Union?
AbbVie Deutschland GmbH & Co KG holds the EU marketing authorisation.